Advertisement

Topics

Cell Therapeutics Limited (UK) Company Profile

11:36 EDT 26th September 2018 | BioPortfolio

At CTI, we're taking a different approach to the treatment of cancer—one focused on developing, acquiring, and commercializing therapies to combat the disease without compromising patient quality of life. Our goal is safer, more effective cancer therapies that can make a meaningful difference to millions.

Frequent conversations with medical professionals and their patients, financial analysts, media representatives and our own employees, have helped us design a Web site that we hope provides the information you seek. Our site includes general corporate information, descriptions of research advances, marketed drugs and product candidates, patient information, and career opportunities. Please explore our site to discover the innovation of our technologies and the commitment of our employees to making cancer a more treatable disease.

Location

1 Ropemaker Street
London
EC2Y 9HT
United Kingdom

Contact

Phone: +44 (0) 208 895 4004
Fax: +44 (0) 208 894 4204
Email: gacton@ctiseattle.com


News Articles [2349 Associated News Articles listed on BioPortfolio]

Rubius Therapeutics Looks to Raise $200 Million in IPO for Red-Cell Therapies

Three months after securing $100 million in a crossover financing round, Cambridge, Mass.-based Rubius Therapeutics is looking at a $200 million initial public offering to support its personalized red...

BrainStorm Cell Therapeutics Announces Positive Interim Safety Analysis

On Thursday (August 23), BrainStorm Cell Therapeutics announced its Phase 3 trial for NurOwn in patients with ALS will be able to continue with no changes. The post BrainStorm Cell Therapeutics Announ...

Pluristem Therapeutics Announces FDA Orphan Drug Designation for PLX cell therapy

Pluristem Therapeutics (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that the U.S. Food and Drug Administra...

TCR2 Therapeutics Snags $125 Million To Expand T-Cell Program

TCR2 Therapeutics has raised $125 million in Series B financing to advance two T-Cell receptor (TCR) programs through clinical proof-of-concept.

A Hat Trick Of Cell And Gene Therapy IPOs: AVRO, MGTA, and UMRX

Last week, AvroBio and Magenta Therapeutics priced their IPOs on the same night. Less than three months earlier, Unum Therapeutics priced its IPO. All three are cell and gene therapy biotechs. The au...

FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

A Vertex Pharmaceuticals partnership with CRISPR Therapeutics to test a genetically engineered drug in patients as a treatment for sickle cell disease has been dealt a setback. The FDA placed a clinic...

Belgian Firm Raises €19M to Fix Spinal Fusion with Cell Therapy

Bone Therapeutics has raised €19.5M through a private placement that will fund the completion of clinical trials testing its cell therapy for spinal fusion and other bone diseases.  Based in Grosel...

Q Therapeutics, ReproCELL form MAGiQ, a CNS diseases JV

Fellow cell therapy companies Q Therapeutics Inc. and ReproCELL Inc. formed a 50/50-owned CNS disease-focused joint venture, which will be headquartered in Japan and known as MAGiQ Therapeutics Inc. R...

PubMed Articles [3243 Associated PubMed Articles listed on BioPortfolio]

Regenerative Rehabilitation: Applied Biophysics Meets Stem Cell Therapeutics.

Therapeutics Incorporating Blood Constituents.

Blood deficiency and dysfunctionality can result in adverse events, which can primarily be treated by transfusion of blood or the re-introduction of properly functioning sub-components. Blood constitu...

Regenerative Rehabilitation: Applied Biophysics Meets Stem Cell Therapeutics.

The emerging field of regenerative rehabilitation integrates biological and bioengineering advances in regenerative medicine with rehabilitative sciences. Here we highlight recent stem cell-based exam...

Cell-SELEX-Based Identification of a Human and Mouse Cross-Reactive Endothelial Cell-Internalizing Aptamer.

Increased interest and insights gained by researchers on the roles of endothelial cells in the pathophysiology of cancer, inflammatory, and cardiovascular diseases have led to the design of pharmacolo...

Dysregulating ClpP: From Antibiotics to Anticancer?

In this issue of Cell Chemical Biology, Wong et al. (2018) identify several dysregulators of a key mitochondrial protease: casein lytic protease P (ClpP). These dysregulators were found to trigger pr...

Clinical Trials [6374 Associated Clinical Trials listed on BioPortfolio]

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease

This study evaluates the safety and clinical benefits of a therapeutics approach of conditioning regimen Cyclophosphamide (Cy) + Thymoglobulin r (ATG) + Granulocyte Colony-Stimulating Fact...

Companies [2228 Associated Companies listed on BioPortfolio]

Magenta Therapeutics

Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based dise...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Opsis Therapeutics

Opsis Therapeutics is a company focused on discovering and developing new medicines to restore vision to patients suffering from retinal diseases. By combining recent innovations ...

Stem Cell Therapeutics Corp.

Stem Cell Therapeutics is a publicly listed Canadian biotechnology company headquartered in Calgary, Alberta. The company is focused on the development and commercialization of Therapeutics that contr...

Fate Therapeutics Inc.

Founded in 2007 on the leading stem cell and developmental biology research, Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. Th...

More Information about "Cell Therapeutics Limited (UK)" on BioPortfolio

We have published hundreds of Cell Therapeutics Limited (UK) news stories on BioPortfolio along with dozens of Cell Therapeutics Limited (UK) Clinical Trials and PubMed Articles about Cell Therapeutics Limited (UK) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Therapeutics Limited (UK) Companies in our database. You can also find out about relevant Cell Therapeutics Limited (UK) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record